A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA® (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST® (an Oral Contraceptive)
This study has been completed.
Study NCT00258063
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: November 22, 2005
Last Updated: May 18, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
